The vascular facet of late-onset Alzheimer's disease: an essential factor in a complex multifactorial disorder
暂无分享,去创建一个
[1] Ping Zhou,et al. Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer A&bgr; Peptides , 2017, Circulation research.
[2] Neil P. Oxtoby,et al. Imaging plus X: multimodal models of neurodegenerative disease , 2017, Current opinion in neurology.
[3] Axel Montagne,et al. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease , 2017, Nature Reviews Neuroscience.
[4] Alan C. Evans,et al. Multifactorial causal model of brain (dis)organization and therapeutic intervention: Application to Alzheimer’s disease , 2017, NeuroImage.
[5] R. Boellaard,et al. Subtle alterations in cerebrovascular reactivity in mild cognitive impairment detected by graph theoretical analysis and not by the standard approach , 2017, NeuroImage: Clinical.
[6] A. Rahmim,et al. Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition , 2017, JAMA.
[7] Julia J. Mack,et al. Perivascular Macrophages Limit Permeability , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[8] Norbert Schuff,et al. Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis , 2016, Nature Communications.
[9] The Paradox of Research on Dementia-Alzheimer's Disease. , 2016, The journal of prevention of Alzheimer's disease.
[10] Christina E. Wierenga,et al. The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer’s Disease , 2016, Cellular and molecular neurobiology.
[11] Zhen Zhao,et al. Establishment and Dysfunction of the Blood-Brain Barrier , 2015, Cell.
[12] Gábor Székely,et al. Reconstructing cerebrovascular networks under local physiological constraints by integer programming , 2015, Medical Image Anal..
[13] Baptiste Lacoste,et al. Neuronal and vascular interactions. , 2015, Annual review of neuroscience.
[14] Sushil Kr. Sharma,et al. Biomarkers in vascular dementia: A recent update , 2015 .
[15] Timothy J Keyes,et al. Structural and functional features of central nervous system lymphatics , 2015, Nature.
[16] Jens Frahm,et al. Inspiration Is the Major Regulator of Human CSF Flow , 2015, The Journal of Neuroscience.
[17] C. Iadecola,et al. Dangerous Leaks: Blood-Brain Barrier Woes in the Aging Hippocampus , 2015, Neuron.
[18] Arthur W. Toga,et al. Blood-Brain Barrier Breakdown in the Aging Human Hippocampus , 2015, Neuron.
[19] C. Nicholson,et al. Clearance systems in the brain-implications for Alzheimer disease. , 2015, Nature reviews. Neurology.
[20] Alan C. Evans,et al. Epidemic Spreading Model to Characterize Misfolded Proteins Propagation in Aging and Associated Neurodegenerative Disorders , 2014, PLoS Comput. Biol..
[21] Hélène Jacqmin-Gadda,et al. Estimating long-term multivariate progression from short-term data , 2014, Alzheimer's & Dementia.
[22] Nick C Fox,et al. A data-driven model of biomarker changes in sporadic Alzheimer's disease , 2014, Alzheimer's & Dementia.
[23] Martin Hallbeck,et al. Spreading of amyloid-β peptides via neuritic cell-to-cell transfer is dependent on insufficient cellular clearance , 2014, Neurobiology of Disease.
[24] J. Keller,et al. Differences in amyloid-β clearance across mouse and human blood–brain barrier models: Kinetic analysis and mechanistic modeling , 2014, Neuropharmacology.
[25] Andrew R. McKinstry-Wu,et al. Connectome: How the Brain’s Wiring Makes Us Who We Are , 2013 .
[26] Arne Traulsen,et al. Extrapolating Weak Selection in Evolutionary Games , 2013, PLoS Comput. Biol..
[27] C. Iadecola,et al. The Pathobiology of Vascular Dementia , 2013, Neuron.
[28] J. Trojanowski,et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. , 2013, Brain : a journal of neurology.
[29] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[30] G. Landreth,et al. Evidence for impaired amyloid β clearance in Alzheimer's disease , 2013, Alzheimer's Research & Therapy.
[31] Martin Hallbeck,et al. Neuron-to-Neuron Transmission of Neurodegenerative Pathology , 2013, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[32] M. Nedergaard,et al. Garbage Truck of the Brain , 2013, Science.
[33] Tammie L. S. Benzinger,et al. Increased in Vivo Amyloid-β42 Production, Exchange, and Loss in Presenilin Mutation Carriers , 2013, Science Translational Medicine.
[34] Jean-Michel Verdier,et al. Increased Amyloid-β Peptide-Induced Memory Deficits in Phospholipid Transfer Protein (PLTP) Gene Knockout Mice , 2013, Neuropsychopharmacology.
[35] Richard S. Frackowiak,et al. Generative FDG-PET and MRI Model of Aging and Disease Progression in Alzheimer's Disease , 2013, PLoS Comput. Biol..
[36] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[37] Gretel Sanabria-Diaz,et al. Studying the topological organization of the cerebral blood flow fluctuations in resting state , 2013, NeuroImage.
[38] David D Shin,et al. Interaction of age and APOE genotype on cerebral blood flow at rest. , 2013, Journal of Alzheimer's disease : JAD.
[39] Jerry L. Prince,et al. A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort , 2012, NeuroImage.
[40] G. E. Vates,et al. A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β , 2012, Science Translational Medicine.
[41] Björn Granseth,et al. Spreading of Neurodegenerative Pathology via Neuron-to-Neuron Transmission of β-Amyloid , 2012, The Journal of Neuroscience.
[42] Sébastien Ourselin,et al. An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease , 2012, NeuroImage.
[43] B. Zlokovic. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.
[44] Claudio Soto,et al. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. , 2011, Seminars in cell & developmental biology.
[45] Jürgen Götz,et al. Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease , 2011, Nature Reviews Neuroscience.
[46] J. Morris,et al. Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.
[47] Ronald Melki,et al. Prion-like transmission of protein aggregates in neurodegenerative diseases , 2010, Nature Reviews Molecular Cell Biology.
[48] M. Diamond,et al. Prion-like mechanisms in neurodegenerative diseases , 2010, Nature Reviews Neuroscience.
[49] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[50] M. Diamond,et al. Propagation of Tau Misfolding from the Outside to the Inside of a Cell* , 2009, Journal of Biological Chemistry.
[51] V. Bautch,et al. Neurovascular development , 2009, Cell adhesion & migration.
[52] R. Deane,et al. Clearance of amyloid-β peptide across the blood-brain barrier: Implication for therapies in Alzheimer’s disease , 2009 .
[53] Shaomin Li,et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.
[54] Angel Ortega,et al. Gender and age-dependent differences in the mitochondrial apoptogenic pathway in Alzheimer's disease. , 2008, Free radical biology & medicine.
[55] P. Thiran,et al. Mapping Human Whole-Brain Structural Networks with Diffusion MRI , 2007, PloS one.
[56] Lester Melie-García,et al. Characterizing brain anatomical connections using diffusion weighted MRI and graph theory , 2007, NeuroImage.
[57] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[58] Olaf Sporns,et al. The Human Connectome: A Structural Description of the Human Brain , 2005, PLoS Comput. Biol..
[59] Berislav V. Zlokovic,et al. Neurovascular mechanisms of Alzheimer's neurodegeneration , 2005, Trends in Neurosciences.
[60] P. Hagmann. From diffusion MRI to brain connectomics , 2005 .
[61] Adam Douglass,et al. Mechanism of Prion Propagation: Amyloid Growth Occurs by Monomer Addition , 2004, PLoS biology.
[62] C. Iadecola. Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[63] J. C. Torre. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics , 2004, The Lancet Neurology.
[64] T. Saido,et al. Reply to: 'Clearance of amyloid β-peptide from brain: transport or metabolism?' , 2000, Nature Medicine.
[65] T. Saido,et al. Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition , 2000, Nature Medicine.
[66] M. Emdin,et al. I027: Circulating levels of cardiac natriuretic peptides measured by highly sensitive and specific IRMA methods in normal subjects and in patients with heart failure , 1998 .
[67] P. Lansbury,et al. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.
[68] R. Reed,et al. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. , 1993, Physiological reviews.
[69] G. Schmid-Schönbein,et al. Microlymphatics and lymph flow. , 1990, Physiological reviews.
[70] J. Lewis,et al. Origins of the neurovascular bundle: interactions between developing nerves and blood vessels in embryonic chick skin. , 1989, The International journal of developmental biology.
[71] W. H. Lewis,et al. The development of the arm in man , 1902 .